HRS-1893 - Jiangsu Hengrui Pharma
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects (clinicaltrials.gov) - Apr 3, 2026 - P1 | N=38 | Completed | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Recruiting ➔ Completed 
Trial completion • Cardiomyopathy • Cardiovascular
http://clinicaltrials.gov/ct2/show/NCT07272330
 
Apr 3, 2026
 
Prev Next